What's the deal with Ammonia in hepatic encephalopathy? A #cirrhosis QI #tweetorial Aims Try to answer this question while also showing 1) Ammonia levels dont matter 2) U should not restrict protein in patients with HE Keywords: "ammonia hypothesis", sarcopenia

biopsy vs radiology? EASL vs #LIRADS criteria? It is not a metter of competition but a collaborative approach to reach the diagnosis of #HCC! Maxime Ronot Paradis valerie EASL Education #EASLCongress #ILC2023 #LiverTwitter

MAESTRO-NASH is a positive trial Resmetirom improved NASH resolution and reduced fibrosis at 52-weeks. It is safe. Is it a landmark study? Yes Will it change NASH? Depends on cost, adherence in real world, and effect on clinical outcomes #EASLCongress #LiverTwitter

Albumin uses, abuses, and future directions in #cirrhosis ✅ 1️⃣SBP 2️⃣after large paracentesis 3️⃣hepatorenal, but don’t overdo it 💩 1️⃣because low levels 2️⃣nonSBP infections 🧐maybe 1️⃣hyponatremia 2️⃣outpatients with ascites, 🧠HE 3️⃣cramps #LiverTwitter

President of The Baveno Cooperation: an EASL Consortium 2030: Anahita Rabiee

✅ out this 💥 Review from Hepatology Communications‼️ 📑 Learn about current and emerging tools for #HCC surveillance🔎! 🧵 #LiverTwitter #OncTwitter #OpenAccess journals.lww.com/hepcomm/Fullte…

Assessing the risk of surgery in patients with cirrhosis I find myself referring to this Hepatology Communications paper by Kaltenbach and Mahmud. Turns out it has been read 1100 times in the last 4 months!! #livertwitter Open access journals.lww.com/hepcomm/Fullte…

Terrific review of the uses for and uncertainties of albumin infusion in #cirrhosis from THE Guadalupe GarciaTsao and Jonel Trebicka in Hepatology For many of these super important questions, the only feasible path to answer is pragmatic trials doi.org/10.1097/hep.00… #livertwitter

#IMbrave050 is the first phase 3 study of adjuvant treatment for #HCC to report positive results. During ESMO - Eur. Oncology is out on The Lancet ‼️doi.org/10.1016/S0140-… #LiverCancerAwarenessMonth

The IF of JCEH is 3 and climbing! Read comment and write to us. Indian Journal of Gastroenterology Anil Ajay Duseja Anand V Kulkarni Juan Pablo (JP) Arab, MD  Keith Siau Sahaj Rathi MD, DM, MRCP

Happy Diwali

Are we heading towards treat all strategy for HBV? Congratulations Daniel Huang wonderful work. Seng Gee Lim Amit G Singal Mark Muthiah ILCA DR AJEET S BHADORIA Arndt Vogel Grace Wong Anjana Pillai Norah Terrault HEPATOLOGY Journal AASLD #livertwitter

#inasl2024kochi

INASL 2024 kochi #inasl2024kochi

INASL 2024 abstract submissions and registration is open. Please visit inasl2024kochi.com #inasl2024kochi

Happy Republic Day #inasl #inasl2024kochi #livertwitter

Surgical risk stratification in cirrhosis by Dr Ana Ostomic, Nadim Mahmud and Dr Raj Reddy. Which one do you use ? Child MELD Mayo Vocal? Learn more about them! Very useful in day to day practice. #livertwitter Liver Fellow Network Hepatology International link.springer.com/article/10.100…

Happy Easter From INASL and INASL-2024, Kochi, Kerala, India 7th - 10th August, 2024 Registration and Abstract Submission are Open.